Diabetes medications and weight loss
Pro Research Analysisby 
Searched over 200M research papers
Diabetes Medications and Weight Loss: Key Drug Classes and Effects
Weight Loss Effects of Diabetes Medications
Many people with type 2 diabetes also struggle with obesity, and some diabetes medications can help with weight loss while others may cause weight gain or have a neutral effect. The most effective diabetes medications for weight loss are glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as liraglutide, semaglutide, and tirzepatide, which can lead to weight loss greater than 5% of initial body weight. Other drugs like canagliflozin, ertugliflozin, dapagliflozin (SGLT-2 inhibitors), and dulaglutide (a GLP-1 RA) result in moderate weight loss between 3.2% and 5%. Medications such as metformin, acarbose, empagliflozin, and exenatide tend to produce mild weight loss, less than 3.2% of initial weight1345+1 MORE.
Medications Associated with Weight Gain or Neutral Effects
Some diabetes medications, including thiazolidinediones (TZDs), sulfonylureas, meglitinides, and insulin, are associated with weight gain. This can make diabetes management more challenging for people who are overweight or obese. Dipeptidyl peptidase-4 (DPP-4) inhibitors and some fixed-ratio insulin/GLP-1 RA combinations are generally weight-neutral, meaning they do not significantly affect body weight24510.
Clinical Implications and Treatment Choices
Given the impact of weight on diabetes outcomes, current guidelines recommend prioritizing medications that are weight-neutral or promote weight loss for people with type 2 diabetes and obesity. Metformin remains the first-line therapy due to its effectiveness, low cost, and potential for mild weight loss. SGLT-2 inhibitors and GLP-1 RAs are increasingly used for their dual benefits of glucose control and weight reduction. In contrast, medications that promote weight gain, such as insulin and sulfonylureas, should be used cautiously, especially in overweight or obese patients2459+1 MORE.
Real-World Outcomes and Lifestyle Interventions
Studies show that even when using medications associated with weight gain, structured lifestyle programs can still help people with diabetes lose weight and improve glycemic control. However, the greatest benefits are seen when combining lifestyle changes with medications that support weight loss68.
Evolving Guidelines and Future Directions
Recent trends in diabetes care emphasize the importance of weight management, with a shift toward prescribing medications that help reduce weight and improve cardiovascular outcomes. Despite this, a large proportion of people with diabetes still receive medications that may cause weight gain, highlighting the need for continued progress in aligning treatment choices with best practices for weight and metabolic health.
Conclusion
In summary, diabetes medications vary widely in their effects on body weight. GLP-1 receptor agonists and SGLT-2 inhibitors are the most effective for weight loss, while metformin offers mild benefits and remains a cornerstone of therapy. Choosing medications that support weight loss or are weight-neutral is increasingly recognized as essential for optimal diabetes management, especially in patients who are overweight or obese. Combining these medications with lifestyle interventions can further enhance weight loss and improve overall health outcomes in diabetes1345+3 MORE.
Sources and full results
Most relevant research papers on this topic